The treatment of multiple ... conceptualize myelin as insulation around a wire. But axons cannot survive for very long without the critical trophic support the myelin sheath provides.

Nearly 50% of MS patients report pronounced fatigue, which has a significantly negative impact on their well-being, a Finnish ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Demyelinating (without myelin sheath) nerve cells occurs in multiple areas of the brain and nervous system. The damaged portions of the axon undergo sclerosis (develop hardened scars). A ...

A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...

Demyelinating (without myelin sheath) nerve cells occurs in multiple areas of the brain and nervous system. The damaged portions of the axon undergo sclerosis (develop hardened scars). A ...

Myelin – produced by Schwann cells in the periphery and oligodendrocytes in the CNS – is defective in diseases such as multiple sclerosis, and many myelin repair strategies aim to mitigate ...

Multiple sclerosis is a chronic and potentially ... Damaging the protective lining, called the myelin sheath, that surrounds nerve cells in the brain and spinal cord. When this lining becomes ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be taken at home on a widespread basis ...

Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. One study shows that people who began treatment when their first ...